Despite technological leaps in treatment and screening, cancer remains one of the leading causes of death globally—but oncology healthtech startups are finding ways to break through. According to PitchBook’s Oncology Healthtech VC Market Snapshot, in spite of operating in a market dominated largely by incumbents, there’s still ample opportunity for startups to innovate and find success. With VC deal value for the sector already surpassing 2023’s at $2.8 billion deployed, investors, too, are bullish on the sector’s prospects.
Read the full article: 2024 Oncology Healthtech VC Market Snapshot //
Source: https://pitchbook.com/news/reports/2024-oncology-healthtech-vc-market-snapshot